Skip to main content
Top
Published in: BMC Health Services Research 1/2010

Open Access 01-12-2010 | Research article

Cholesterol treatment with statins: Who is left out and who makes it to goal?

Authors: Peter Franks, Daniel Tancredi, Paul Winters, Kevin Fiscella

Published in: BMC Health Services Research | Issue 1/2010

Login to get access

Abstract

Background

Whether patient socio-demographic characteristics (age, sex, race/ethnicity, income, and education) are independently associated with failure to receive indicated statin therapy and/or to achieve low density lipoprotein cholesterol (LDL-C) therapy goals are not known. We examined socio-demographic factors associated with a) eligibility for statin therapy among those not on statins, and b) achievement of statin therapy goals.

Methods

Adults (21-79 years) participating in the United States (US) National Health and Nutrition Examination Surveys, 1999-2006 were studied. Statin eligibility and achievement of target LDL-C was assessed using the US Third Adult Treatment Panel (ATP III) on Treatment of High Cholesterol guidelines.

Results

Among 6,043 participants not taking statins, 10.4% were eligible. Adjusted predictors of statin eligibility among statin non-users were being older, male, poorer, and less educated. Hispanics were less likely to be eligible but not using statins, an effect that became non-significant with adjustment for language usually spoken at home. Among 537 persons taking statins, 81% were at LDL-C goal. Adjusted predictors of goal failure among statin users were being male and poorer. These risks were not attenuated by adjustment for healthcare access or utilization.

Conclusion

Among person's not taking statins, the socio-economically disadvantaged are more likely to be eligible and among those on statins, the socio-economically disadvantaged are less likely to achieve statin treatment goals. Further study is needed to identify specific amenable patient and/or physician factors that contribute to these disparities.
Appendix
Available only for authorised users
Literature
1.
go back to reference The Henry J Kaiser Family Foundation: Ethnic differences in Cardiac Care: The Weight of the Evidence. 2002, Menlo Park, Henry J Kaiser Family Foundation The Henry J Kaiser Family Foundation: Ethnic differences in Cardiac Care: The Weight of the Evidence. 2002, Menlo Park, Henry J Kaiser Family Foundation
2.
go back to reference Basu J, Mobley LR: Trends in racial disparities among the elderly for selected procedures. Med Care Res & Rev. 2008, 65: 617-637. 10.1177/1077558708318284.CrossRef Basu J, Mobley LR: Trends in racial disparities among the elderly for selected procedures. Med Care Res & Rev. 2008, 65: 617-637. 10.1177/1077558708318284.CrossRef
3.
go back to reference Field TS, Doubeni C, Fox MP, Buist DS, Wei F, Geiger AM, et al: Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008, 23: 158-163. 10.1007/s11606-007-0471-2.CrossRefPubMed Field TS, Doubeni C, Fox MP, Buist DS, Wei F, Geiger AM, et al: Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008, 23: 158-163. 10.1007/s11606-007-0471-2.CrossRefPubMed
4.
go back to reference Hernandez AF, Fonarow GC, Liang L, Al Khatib SM, Curtis LH, LaBresh KA, et al: Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007, 298: 1525-1532. 10.1001/jama.298.13.1525.CrossRefPubMed Hernandez AF, Fonarow GC, Liang L, Al Khatib SM, Curtis LH, LaBresh KA, et al: Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007, 298: 1525-1532. 10.1001/jama.298.13.1525.CrossRefPubMed
5.
go back to reference Shields AE, Burke W, Levy DE: Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med. 2008, 10: 404-414. 10.1097/GIM.0b013e3181770184.CrossRefPubMedPubMedCentral Shields AE, Burke W, Levy DE: Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med. 2008, 10: 404-414. 10.1097/GIM.0b013e3181770184.CrossRefPubMedPubMedCentral
6.
go back to reference Shi L, Stevens GD: Vulnerable Populations in the United States. 2005, San Francisco, CA: Jossey-Bass Shi L, Stevens GD: Vulnerable Populations in the United States. 2005, San Francisco, CA: Jossey-Bass
7.
go back to reference Pham HH, Alexander GC, O'Malley AS: Physician consideration of patients' out-of-pocket costs in making common clinical decisions. Arch Intern Med. 2007, 167: 663-668. 10.1001/archinte.167.7.663.CrossRefPubMed Pham HH, Alexander GC, O'Malley AS: Physician consideration of patients' out-of-pocket costs in making common clinical decisions. Arch Intern Med. 2007, 167: 663-668. 10.1001/archinte.167.7.663.CrossRefPubMed
8.
go back to reference Stanley A, DeLia D, Cantor JC: Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996-2001. J Natl Med Assoc. 2007, 99: 201-207.PubMedPubMedCentral Stanley A, DeLia D, Cantor JC: Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996-2001. J Natl Med Assoc. 2007, 99: 201-207.PubMedPubMedCentral
9.
go back to reference Ferris TG, Kuhlthau K, Ausiello J, Perrin J, Kahn R: Are minority children the last to benefit from a new technology? Technology diffusion and inhaled corticosteriods for asthma. Med Care. 2006, 44: 81-86. 10.1097/01.mlr.0000188914.47033.cd.CrossRefPubMed Ferris TG, Kuhlthau K, Ausiello J, Perrin J, Kahn R: Are minority children the last to benefit from a new technology? Technology diffusion and inhaled corticosteriods for asthma. Med Care. 2006, 44: 81-86. 10.1097/01.mlr.0000188914.47033.cd.CrossRefPubMed
10.
go back to reference Crystal S, Sambamoorthi U, Merzel C: The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts. Health Serv Res. 1995, 30: 593-614.PubMedPubMedCentral Crystal S, Sambamoorthi U, Merzel C: The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts. Health Serv Res. 1995, 30: 593-614.PubMedPubMedCentral
11.
go back to reference Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL: Primary care physicians who treat blacks and whites. N Engl J Med. 2004, 351: 575-84. 10.1056/NEJMsa040609.CrossRefPubMed Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL: Primary care physicians who treat blacks and whites. N Engl J Med. 2004, 351: 575-84. 10.1056/NEJMsa040609.CrossRefPubMed
12.
go back to reference Asch SM, Kerr EA, Keesey J, Adams JL, Setodji CM, Malik S, et al: Who is at greatest risk for receiving poor-quality health care?. N Engl J Med. 2006, 354: 1147-1156. 10.1056/NEJMsa044464.CrossRefPubMed Asch SM, Kerr EA, Keesey J, Adams JL, Setodji CM, Malik S, et al: Who is at greatest risk for receiving poor-quality health care?. N Engl J Med. 2006, 354: 1147-1156. 10.1056/NEJMsa044464.CrossRefPubMed
13.
go back to reference Yancy CW, Abraham WT, Albert NM, Clare R, Stough WG, Gheorghiade M, et al: Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol. 2008, 51: 1675-1684. 10.1016/j.jacc.2008.01.028.CrossRefPubMed Yancy CW, Abraham WT, Albert NM, Clare R, Stough WG, Gheorghiade M, et al: Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol. 2008, 51: 1675-1684. 10.1016/j.jacc.2008.01.028.CrossRefPubMed
14.
go back to reference Vaccarino V, Rathore SS, Wenger NK, Frederick PD, Abramson JL, Barron HV, et al: Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005, 353: 671-682. 10.1056/NEJMsa032214.CrossRefPubMedPubMedCentral Vaccarino V, Rathore SS, Wenger NK, Frederick PD, Abramson JL, Barron HV, et al: Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005, 353: 671-682. 10.1056/NEJMsa032214.CrossRefPubMedPubMedCentral
15.
go back to reference Ma J, Stafford RS: Screening, treatment, and control of hypertension in US private physician offices, 2003-2004. Hypertension. 2008, 51: 1275-1281. 10.1161/HYPERTENSIONAHA.107.107086.CrossRefPubMedPubMedCentral Ma J, Stafford RS: Screening, treatment, and control of hypertension in US private physician offices, 2003-2004. Hypertension. 2008, 51: 1275-1281. 10.1161/HYPERTENSIONAHA.107.107086.CrossRefPubMedPubMedCentral
16.
go back to reference Ford ES, Mokdad AH, Giles WH, Mensah GA: Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation. 2003, 107: 2185-2189. 10.1161/01.CIR.0000066320.27195.B4.CrossRefPubMed Ford ES, Mokdad AH, Giles WH, Mensah GA: Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation. 2003, 107: 2185-2189. 10.1161/01.CIR.0000066320.27195.B4.CrossRefPubMed
17.
go back to reference Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC: Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or = 65 years of age. Am J Cardiol. 2007, 100: 1061-1067. 10.1016/j.amjcard.2007.04.052.CrossRefPubMed Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC: Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or = 65 years of age. Am J Cardiol. 2007, 100: 1061-1067. 10.1016/j.amjcard.2007.04.052.CrossRefPubMed
18.
go back to reference Campione JR, Sleath B, Biddle AK, Weinberger M: The influence of physicians' guideline compliance on patients' statin adherence: a retrospective cohort study. Am J Ger Pharmacother. 2005, 3: 229-239. 10.1016/S1543-5946(05)00077-2.CrossRef Campione JR, Sleath B, Biddle AK, Weinberger M: The influence of physicians' guideline compliance on patients' statin adherence: a retrospective cohort study. Am J Ger Pharmacother. 2005, 3: 229-239. 10.1016/S1543-5946(05)00077-2.CrossRef
19.
go back to reference Ma J, Sehgal NL, Ayanian JZ, Stafford RS: National trends in statin use by coronary heart disease risk category. PLoS Medicine/Public Library of Science. 2005, 2: e123. Ma J, Sehgal NL, Ayanian JZ, Stafford RS: National trends in statin use by coronary heart disease risk category. PLoS Medicine/Public Library of Science. 2005, 2: e123.
20.
go back to reference O'Meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST: Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med. 2004, 164: 1313-1318. 10.1001/archinte.164.12.1313.CrossRefPubMed O'Meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST: Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med. 2004, 164: 1313-1318. 10.1001/archinte.164.12.1313.CrossRefPubMed
21.
go back to reference Mann D, Reynolds K, Smith D, Muntner P: Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother. 2008, 42: 1208-1215. 10.1345/aph.1L181.CrossRefPubMed Mann D, Reynolds K, Smith D, Muntner P: Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother. 2008, 42: 1208-1215. 10.1345/aph.1L181.CrossRefPubMed
22.
go back to reference Yood MU, McCarthy BD, Kempf J, Kucera GP, Wells K, Oliveria S, et al: Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy. Am Heart J. 2006, 152: 777-784. 10.1016/j.ahj.2006.02.036.CrossRefPubMed Yood MU, McCarthy BD, Kempf J, Kucera GP, Wells K, Oliveria S, et al: Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy. Am Heart J. 2006, 152: 777-784. 10.1016/j.ahj.2006.02.036.CrossRefPubMed
23.
go back to reference Williams ML, Morris MT, Ahmad U, Yousseff M, Li W, Ertel N, et al: Racial differences in compliance with NCEP-II recommendations for secondary prevention at a Veterans Affairs medical center. Ethn & Dis. 2002, 12: S1-62. Williams ML, Morris MT, Ahmad U, Yousseff M, Li W, Ertel N, et al: Racial differences in compliance with NCEP-II recommendations for secondary prevention at a Veterans Affairs medical center. Ethn & Dis. 2002, 12: S1-62.
27.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef
28.
go back to reference Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004, 110: 227-239. 10.1161/01.CIR.0000133317.49796.0E.CrossRefPubMed Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004, 110: 227-239. 10.1161/01.CIR.0000133317.49796.0E.CrossRefPubMed
29.
30.
go back to reference Hyre AD, Muntner P, Menke A, Raggi P, He J: Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol. 2007, 17: 548-555. 10.1016/j.annepidem.2007.01.032.CrossRefPubMed Hyre AD, Muntner P, Menke A, Raggi P, He J: Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol. 2007, 17: 548-555. 10.1016/j.annepidem.2007.01.032.CrossRefPubMed
31.
go back to reference Fiscella K, Franks P, Gold MR, Clancy CM: Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000, 283: 2579-2584. 10.1001/jama.283.19.2579.CrossRefPubMed Fiscella K, Franks P, Gold MR, Clancy CM: Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA. 2000, 283: 2579-2584. 10.1001/jama.283.19.2579.CrossRefPubMed
32.
go back to reference Rahimi AR, Spertus JA, Reid KJ, Bernheim SM, Krumholz HM: Financial barriers to health care and outcomes after acute myocardial infarction. JAMA. 2007, 297: 1063-1072. 10.1001/jama.297.10.1063.CrossRefPubMed Rahimi AR, Spertus JA, Reid KJ, Bernheim SM, Krumholz HM: Financial barriers to health care and outcomes after acute myocardial infarction. JAMA. 2007, 297: 1063-1072. 10.1001/jama.297.10.1063.CrossRefPubMed
33.
go back to reference Khanderia U, Townsend KA, Erickson SR, Vlasnik J, Prager RL, Eagle KA: Medication adherence following coronary artery bypass graft surgery: assessment of beliefs and attitudes. An Pharmacother. 2008, 42: 192-199. 10.1345/aph.1K497.CrossRef Khanderia U, Townsend KA, Erickson SR, Vlasnik J, Prager RL, Eagle KA: Medication adherence following coronary artery bypass graft surgery: assessment of beliefs and attitudes. An Pharmacother. 2008, 42: 192-199. 10.1345/aph.1K497.CrossRef
34.
go back to reference Rasmussen JN, Gislason GH, Rasmussen S, Abildstrom SZ, Schramm TK, Kober L, et al: Use of statins and beta-blockers after acute myocardial infarction according to income and education. J Epidemiol & Community Health. 2007, 61: 1091-1097. 10.1136/jech.2006.055525.CrossRef Rasmussen JN, Gislason GH, Rasmussen S, Abildstrom SZ, Schramm TK, Kober L, et al: Use of statins and beta-blockers after acute myocardial infarction according to income and education. J Epidemiol & Community Health. 2007, 61: 1091-1097. 10.1136/jech.2006.055525.CrossRef
35.
go back to reference Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J: Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002, 288: 455-461. 10.1001/jama.288.4.455.CrossRefPubMed Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J: Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002, 288: 455-461. 10.1001/jama.288.4.455.CrossRefPubMed
36.
go back to reference Gellad WF, Haas JS, Safran DG: Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med. 2007, 22: 1572-1578. 10.1007/s11606-007-0385-z.CrossRefPubMedPubMedCentral Gellad WF, Haas JS, Safran DG: Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med. 2007, 22: 1572-1578. 10.1007/s11606-007-0385-z.CrossRefPubMedPubMedCentral
37.
go back to reference Mann DM, Allegrante JP, Natarajan S, Halm EA, Charlson M: Predictors of adherence to statins for primary prevention. Cardiovasc Drugs Ther. 2007, 21: 311-316. 10.1007/s10557-007-6040-4.CrossRefPubMed Mann DM, Allegrante JP, Natarajan S, Halm EA, Charlson M: Predictors of adherence to statins for primary prevention. Cardiovasc Drugs Ther. 2007, 21: 311-316. 10.1007/s10557-007-6040-4.CrossRefPubMed
38.
go back to reference Choudhry NK: Copayment levels and medication adherence: less is more. Circulation. 2009, 119: 365-367. 10.1161/CIRCULATIONAHA.108.829655.CrossRefPubMed Choudhry NK: Copayment levels and medication adherence: less is more. Circulation. 2009, 119: 365-367. 10.1161/CIRCULATIONAHA.108.829655.CrossRefPubMed
39.
go back to reference Ridley DB, Axelsen KJ: Impact of Medicaid preferred drug lists on therapeutic adherence. Pharmacoeconomics. 2006, 24 (Suppl): 78-10.2165/00019053-200624003-00006. Ridley DB, Axelsen KJ: Impact of Medicaid preferred drug lists on therapeutic adherence. Pharmacoeconomics. 2006, 24 (Suppl): 78-10.2165/00019053-200624003-00006.
40.
go back to reference KetchAmerican Journal of D, Epstein AJ: Which physicians are affected most by Medicaid preferred drug lists for statins and antihypertensives?. Pharmacoeconomics. 2006, 24 (Suppl): 40. KetchAmerican Journal of D, Epstein AJ: Which physicians are affected most by Medicaid preferred drug lists for statins and antihypertensives?. Pharmacoeconomics. 2006, 24 (Suppl): 40.
41.
go back to reference Stocks NP, Ryan P, McElroy H, Allan J: Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study. Med J Aust. 2004, 180: 229-231.PubMed Stocks NP, Ryan P, McElroy H, Allan J: Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study. Med J Aust. 2004, 180: 229-231.PubMed
42.
go back to reference Thomsen RW, Johnsen SP, Olesen AV, Mortensen JT, Boggild H, Olsen J, et al: Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol. 2005, 60: 534-542. 10.1111/j.1365-2125.2005.02494.x.CrossRefPubMedPubMedCentral Thomsen RW, Johnsen SP, Olesen AV, Mortensen JT, Boggild H, Olsen J, et al: Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol. 2005, 60: 534-542. 10.1111/j.1365-2125.2005.02494.x.CrossRefPubMedPubMedCentral
43.
go back to reference Fiscella K, Tancredi D, Franks P: Adding socioeconomic status to Framingham scoring to reduce disparities in coronary risk assessment. Am Heart J. 2009, 157: 988-994. 10.1016/j.ahj.2009.03.019.CrossRefPubMed Fiscella K, Tancredi D, Franks P: Adding socioeconomic status to Framingham scoring to reduce disparities in coronary risk assessment. Am Heart J. 2009, 157: 988-994. 10.1016/j.ahj.2009.03.019.CrossRefPubMed
44.
go back to reference Chang VW, Lauderdale DS: Fundamental cause theory, technological innovation, and health disparities: the case of cholesterol in the era of statins. J Health & Social Behav. 2009, 50: 245-260. 10.1177/002214650905000301.CrossRef Chang VW, Lauderdale DS: Fundamental cause theory, technological innovation, and health disparities: the case of cholesterol in the era of statins. J Health & Social Behav. 2009, 50: 245-260. 10.1177/002214650905000301.CrossRef
45.
go back to reference Lutsey PL, Diez Roux AV, Jacobs DR, Burke GL, Harman J, Shea S, et al: Associations of acculturation and socioeconomic status with subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis. Am J Public Health. 2008, 98: 1963-1970. 10.2105/AJPH.2007.123844.CrossRefPubMedPubMedCentral Lutsey PL, Diez Roux AV, Jacobs DR, Burke GL, Harman J, Shea S, et al: Associations of acculturation and socioeconomic status with subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis. Am J Public Health. 2008, 98: 1963-1970. 10.2105/AJPH.2007.123844.CrossRefPubMedPubMedCentral
46.
go back to reference Singh GK, Siahpush M: Ethnic-immigrant differentials in health behaviors, morbidity, and cause-specific mortality in the United States: an analysis of two national data bases. Hum Biol. 2002, 74: 83-109. 10.1353/hub.2002.0011.CrossRefPubMed Singh GK, Siahpush M: Ethnic-immigrant differentials in health behaviors, morbidity, and cause-specific mortality in the United States: an analysis of two national data bases. Hum Biol. 2002, 74: 83-109. 10.1353/hub.2002.0011.CrossRefPubMed
47.
go back to reference Jerant A, Arellanes R, Franks P: Health status among US Hispanics: ethnic variation, nativity, and language moderation. Med Care. 2008, 46: 709-717. 10.1097/MLR.0b013e3181789431.CrossRefPubMed Jerant A, Arellanes R, Franks P: Health status among US Hispanics: ethnic variation, nativity, and language moderation. Med Care. 2008, 46: 709-717. 10.1097/MLR.0b013e3181789431.CrossRefPubMed
48.
Metadata
Title
Cholesterol treatment with statins: Who is left out and who makes it to goal?
Authors
Peter Franks
Daniel Tancredi
Paul Winters
Kevin Fiscella
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2010
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-10-68

Other articles of this Issue 1/2010

BMC Health Services Research 1/2010 Go to the issue